You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 2 No. 1, Jan-Mar 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Ethics and Public Policy
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Editor's Comment

Wayne F. Larrabee Jr, MD

Arch Facial Plast Surg. 2000;2:62.

Since this article does not have an abstract, we have provided the first 75 words of the full text and any section headings.

New medical devices are important to improve patient care in facial plastic surgery. The following breif articles clarify the policies of the US Food and Drug Administration (FDA) from the perspectives of a medical officer of the FDA (Dr Jaffee) and 2 clinicians actively involved in the development of new devices (Drs Blitzer and Binder). Increased cooperation between the FDA and clinical physicians can only improve patient outcomes and safety.

Editor







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.